Phase 1 CML (Chronic Myelogenous Leukemia) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

CML (Chronic Myelogenous Leukemia)

Mendus24 enrolled1 locationNCT07651878

Recruiting

Phase 1

ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants

CML (Chronic Myelogenous Leukemia)Chronic Phase CML

Enliven Therapeutics21 enrolled4 locationsNCT06787144